USPTO Patent Post-Issuance Proceedings Under the America Invents Act (AIA) -- Considerations Impacting the Healthcare and Technology Sectors
May 6, 2014 | 5:00 - 7:30p.m. | 2.0 NY/NJ CLE credit hours
Location: The event will take place at The Newark Club. For further information about the event, please contact Teresa Rizzo at email@example.com.
More than 18 months have passed since the first petitions for patent post-issuance proceedings were filed in the USPTO in September 2012. This program will examine lessons learned over this time, with special emphasis on emerging strategies and other considerations impacting the Healthcare and Technology Sectors.
Featuring insights from representatives of IBM, Johnson & Johnson, Pfizer and others, and moderated by members of Gibbons’ Intellectual Property Practice Group.